Variant report

Variant	esv2753951
Chromosome Location	chr17:16660721-16848750
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:1771)
CpG islands
(count:1283)
Chromatin interactive
region (count:23)
LncRNA
region (count:23)
Mature miRNA
region (count: 0)
miRNA target
sites (count:2)

(count:1771 , 50 per page) page: 1 2 3 4 5 6 7 ... 36

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BACH1	chr17:16719169-16719457	K562	blood:	n/a	n/a
2	BACH1	chr17:16719341-16719384	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr17:16711019-16711268	GM12878	blood:	n/a	chr17:16711188-16711198 chr17:16711187-16711198
4	BATF	chr17:16789928-16790235	GM12878	blood:	n/a	chr17:16790094-16790105
5	BATF	chr17:16789957-16790289	GM12878	blood:	n/a	chr17:16790094-16790105
6	BATF	chr17:16710949-16711369	GM12878	blood:	n/a	chr17:16711188-16711198 chr17:16711187-16711198
7	BATF	chr17:16788586-16788829	GM12878	blood:	n/a	chr17:16788732-16788742 chr17:16788731-16788742
8	BCL3	chr17:16812400-16812714	GM12878	blood:	n/a	n/a
9	BCL3	chr17:16809248-16809511	GM12878	blood:	n/a	n/a
10	BCL3	chr17:16838669-16839490	GM12878	blood:	n/a	n/a
11	BCL3	chr17:16812475-16812689	GM12878	blood:	n/a	n/a
12	BCLAF1	chr17:16825664-16826009	GM12878	blood:	n/a	n/a
13	BHLHE40	chr17:16776637-16776774	A549	lung:	n/a	n/a
14	BHLHE40	chr17:16842299-16842597	GM12878	blood:	n/a	n/a
15	BRCA1	chr17:16812266-16812267	GM12878	blood:	n/a	n/a
16	BRCA1	chr17:16764549-16764560	Hela-S3	cervix:	n/a	n/a
17	BRCA1	chr17:16776669-16776811	H1-hESC	embryonic stem cell:	n/a	n/a
18	CEBPB	chr17:16781616-16781809	IMR90	lung:	n/a	chr17:16781621-16781632 chr17:16781621-16781634
19	CEBPB	chr17:16663012-16663205	IMR90	lung:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
20	CEBPB	chr17:16764004-16764108	HepG2	liver:	n/a	chr17:16764008-16764019
21	CEBPB	chr17:16663042-16663112	K562	blood:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
22	CEBPB	chr17:16676545-16676704	Hela-S3	cervix:	n/a	n/a
23	CEBPB	chr17:16773866-16773956	A549	lung:	n/a	n/a
24	CEBPB	chr17:16808916-16808945	H1-hESC	embryonic stem cell:	n/a	n/a
25	CEBPB	chr17:16781507-16781814	HepG2	liver:	n/a	chr17:16781621-16781632 chr17:16781621-16781634
26	CEBPB	chr17:16790196-16790255	HepG2	liver:	n/a	n/a
27	CEBPB	chr17:16771631-16771906	A549	lung:	n/a	chr17:16771790-16771801
28	CEBPB	chr17:16764555-16764730	Hela-S3	cervix:	n/a	n/a
29	CEBPB	chr17:16763881-16764076	A549	lung:	n/a	chr17:16764008-16764019
30	CEBPB	chr17:16808111-16808206	Hela-S3	cervix:	n/a	n/a
31	CEBPB	chr17:16790136-16790315	Hela-S3	cervix:	n/a	n/a
32	CEBPB	chr17:16771713-16771889	HepG2	liver:	n/a	chr17:16771790-16771801
33	CEBPB	chr17:16663026-16663220	A549	lung:	n/a	chr17:16663087-16663100 chr17:16663087-16663100 chr17:16663087-16663098 chr17:16663087-16663100 chr17:16663089-16663098
34	CEBPB	chr17:16763876-16764183	Hela-S3	cervix:	n/a	chr17:16764008-16764019
35	CEBPB	chr17:16768234-16768445	Hela-S3	cervix:	n/a	n/a
36	CHD2	chr17:16764544-16764744	Hela-S3	cervix:	n/a	n/a
37	CTCF	chr17:16819342-16819634	GM19239	blood:	n/a	chr17:16819475-16819491 chr17:16819477-16819486 chr17:16819479-16819489 chr17:16819474-16819492 chr17:16819476-16819497
38	CTCF	chr17:16764620-16764770	HRPEpiC	eye:	n/a	n/a
39	CTCF	chr17:16825780-16825930	AG09319	gingival:	n/a	n/a
40	CTCF	chr17:16776540-16776690	NHDF-neo	bronchial:	n/a	n/a
41	CTCF	chr17:16825480-16825630	RPTEC	kidney:	n/a	n/a
42	CTCF	chr17:16764623-16764825	Gliobla	brain:	n/a	n/a
43	CTCF	chr17:16823303-16823588	K562	blood:	n/a	n/a
44	CTCF	chr17:16733626-16733849	MCF-7	breast:	n/a	n/a
45	CTCF	chr17:16764635-16764771	K562	blood:	n/a	n/a
46	CTCF	chr17:16722203-16722355	H1-hESC	embryonic stem cell:	n/a	n/a
47	CTCF	chr17:16825740-16825890	GM06990	blood:	n/a	n/a
48	CTCF	chr17:16709080-16709230	HMF	breast:	n/a	n/a
49	CTCF	chr17:16825780-16825930	HMF	breast:	n/a	n/a
50	CTCF	chr17:16823340-16823490	HEK293	kidney:	n/a	n/a

(count:1283 , 50 per page) page: 1 2 3 4 5 6 7 ... 26

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr17:16838321-16838371	GM12892	blood:	n/a
2	chr17:16797159-16797209	AG04450	lung:	fetal
3	chr17:16838321-16838371	GM12892	blood:	n/a
4	chr17:16797159-16797209	AG04450	lung:	fetal
5	chr17:16736463-16736513	AG09309	skin:	n/a
6	chr17:16840933-16840983	HEEpiC	esophagus:	n/a
7	chr17:16736463-16736513	RPTEC	kidney:	n/a
8	chr17:16797273-16797323	MCF10A-Er-Src	breast:	n/a
9	chr17:16690173-16690223	BJ	skin:	n/a
10	chr17:16688816-16688866	HUVEC	blood vessel:	n/a
11	chr17:16690169-16690219	CMK	blood:	n/a
12	chr17:16797159-16797209	LNCaP	prostate:	n/a
13	chr17:16840933-16840983	GM12892	blood:	n/a
14	chr17:16690173-16690223	HL-60	blood:	n/a
15	chr17:16842469-16842519	NB4	blood:	n/a
16	chr17:16797273-16797323	GM19239	blood:	n/a
17	chr17:16690173-16690223	MCF10A-Er-Src	breast:	n/a
18	chr17:16797159-16797209	RPTEC	kidney:	n/a
19	chr17:16693633-16693683	HepG2	liver:	n/a
20	chr17:16690169-16690219	AG09309	skin:	n/a
21	chr17:16843026-16843076	SK-N-SH_RA	brain:	n/a
22	chr17:16690169-16690219	PrEC	prostate:	n/a
23	chr17:16838510-16838560	HepG2	liver:	n/a
24	chr17:16838176-16838226	SK-N-SH_RA	brain:	n/a
25	chr17:16843026-16843076	AoSMC	blood vessel:	n/a
26	chr17:16840933-16840983	SK-N-SH	brain:	n/a
27	chr17:16838321-16838371	HNPCEpiC	eye:	n/a
28	chr17:16736463-16736513	AG09319	gingival:	n/a
29	chr17:16797273-16797323	HPAEpiC	pulmonary alveolar:	n/a
30	chr17:16838176-16838226	PrEC	prostate:	n/a
31	chr17:16838427-16838477	HRCEpiC	kidney:	n/a
32	chr17:16757356-16757406	GM06990	blood:	n/a
33	chr17:16734819-16734869	ECC-1	luminal epithelium:	n/a
34	chr17:16797017-16797067	HUVEC	blood vessel:	n/a
35	chr17:16797017-16797067	LNCaP	prostate:	n/a
36	chr17:16757305-16757355	SK-N-SH_RA	brain:	n/a
37	chr17:16836322-16836372	SKMC	muscle:	n/a
38	chr17:16838176-16838226	HUVEC	blood vessel:	n/a
39	chr17:16838427-16838477	AG10803	skin:	n/a
40	chr17:16838176-16838226	AG09309	skin:	n/a
41	chr17:16838236-16838286	ovcar-3	ovarian:	n/a
42	chr17:16734819-16734869	GM12878	blood:	n/a
43	chr17:16843026-16843076	HPAEpiC	pulmonary alveolar:	n/a
44	chr17:16842469-16842519	NHBE	bronchial:	n/a
45	chr17:16838427-16838477	PrEC	prostate:	n/a
46	chr17:16688816-16688866	IMR90	lung:	fetal
47	chr17:16797017-16797067	K562	blood:	n/a
48	chr17:16693633-16693683	MCF10A-Er-Src	breast:	n/a
49	chr17:16737096-16737146	ProgFib	skin:	n/a
50	chr17:16693633-16693683	LNCaP	prostate:	n/a

(count:23 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr17:16817372..16819591-chr17:16821854..16823935,2	MCF-7	breast:
2	chr17:16817372..16819591-chr17:16821854..16823935,2	MCF-7	breast:
3	chr17:16721818..16722353-chr17:16776583..16777108,2	MCF-7	breast:
4	chr17:16844584..16846721-chr17:16858506..16861138,2	MCF-7	breast:
5	chr17:16810205..16812865-chr17:16818453..16820548,2	MCF-7	breast:
6	chr17:16439156..16440810-chr17:16832708..16834680,2	MCF-7	breast:
7	chr17:16810205..16812865-chr17:16818453..16820548,2	MCF-7	breast:
8	chr17:16825314..16827941-chr17:16845624..16848889,3	MCF-7	breast:
9	chr17:16826192..16826763-chr17:16845300..16846108,3	MCF-7	breast:
10	chr17:16828602..16830986-chr17:16831048..16832732,2	MCF-7	breast:
11	chr17:16838629..16840904-chr17:16844265..16846336,2	MCF-7	breast:
12	chr17:16825450..16826310-chr17:16894599..16895108,2	MCF-7	breast:
13	chr17:16839251..16842055-chr17:16843809..16846753,2	K562	blood:
14	chr17:16819016..16819930-chr17:16894369..16895346,5	MCF-7	breast:
15	chr17:16784922..16787392-chr17:16982105..16984669,2	K562	blood:
16	chr17:16825667..16826312-chr17:16900864..16901397,2	MCF-7	breast:
17	chr17:16826192..16826763-chr17:16845300..16846108,3	MCF-7	breast:
18	chr17:16721818..16722353-chr17:16776583..16777108,2	MCF-7	breast:
19	chr17:16844634..16847567-chr17:17108440..17110491,2	MCF-7	breast:
20	chr17:16825314..16827941-chr17:16845624..16848889,3	MCF-7	breast:
21	chr17:16756059..16758999-chr17:16760586..16763495,2	K562	blood:
22	chr17:16825418..16826776-chr17:16894392..16895364,7	MCF-7	breast:
23	chr17:16828602..16830986-chr17:16831048..16832732,2	MCF-7	breast:

(count:23 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-KRT17P1-2	chr17:16750949-16751252	NONHSAT146019
2	lnc-CCDC144A-1	chr17:16707941-16707992	ENSG00000264729.1
3	lnc-CCDC144A-4	chr17:16735634-16735881	NONHSAT146016
4	lnc-TNFRSF13B-5	chr17:16832835-16833722	NONHSAT146027
5	lnc-TNFRSF13B-5	chr17:16835744-16835819	NONHSAT146028
6	lnc-TNFRSF13B-5	chr17:16832530-16832633	NONHSAT146027
7	lnc-TNFRSF13B-5	chr17:16835485-16835567	NONHSAT146027
8	lnc-KRT17P1-1	chr17:16691922-16692548	ENSG00000264673.1
9	lnc-TNFRSF13B-5	chr17:16835744-16835819	NONHSAT146027
10	lnc-AC104024.2.1-3	chr17:16692215-16692721	NONHSAT146007
11	lnc-TNFRSF13B-5	chr17:16835485-16835567	NONHSAT146028
12	lnc-TNFRSF13B-7	chr17:16796512-16796743	NONHSAT146023
13	lnc-TNFRSF13B-6	chr17:16824240-16824755	NONHSAT146024
14	lnc-TNFRSF13B-5	chr17:16832595-16832633	NONHSAT146028
15	lnc-KRT17P1-1	chr17:16691562-16691620	ENSG00000264673.1
16	lnc-TNFRSF13B-5	chr17:16836101-16836106	NONHSAT146028
17	lnc-KRT17P1-2	chr17:16751411-16751727	NONHSAT146019
18	lnc-AC104024.2.1-3	chr17:16692057-16693815	NONHSAT146006
19	lnc-TNFRSF13B-5	chr17:16832835-16833722	NONHSAT146028
20	lnc-TNFRSF13B-6	chr17:16820038-16821669	NONHSAT146024
21	lnc-TNFRSF13B-6	chr17:16825340-16825392	NONHSAT146024
22	lnc-CCDC144A-1	chr17:16708772-16709021	ENSG00000264729.1
23	lnc-CCDC144A-4	chr17:16734662-16734742	NONHSAT146016

No data

(count:2 , 50 per page) page: 1

No.	miRNA target gene	miRNA name	Chromosome Location	mirBase accession
1	CCDC144A	hsa-miR-26b-5p	chr17:16677653-16677674
2	LOC162632	hsa-miR-26b-5p	chr17:16707023-16707045

Variant related genes	Relation type
ENSG00000264673	TF binding region
COTL1P1	TF binding region
USP32P1	TF binding region
ENSG00000272815	TF binding region
SRP68P1	TF binding region
ENSG00000264729	TF binding region
ENSG00000205312	TF binding region
ENSG00000226145	TF binding region
KRT16P2	TF binding region
FAM106CP	TF binding region
TNFRSF13B	TF binding region
TBC1D27	TF binding region
ENSG00000265853	TF binding region
ENSG00000264892	TF binding region
KRT17P1	TF binding region
ENSG00000264673	CpG island
COTL1P1	CpG island
USP32P1	CpG island
ENSG00000272815	CpG island
SRP68P1	CpG island
ENSG00000264729	CpG island
ENSG00000205312	CpG island
ENSG00000226145	CpG island
KRT16P2	CpG island
FAM106CP	CpG island
TNFRSF13B	CpG island
TBC1D27	CpG island
ENSG00000265853	CpG island
ENSG00000264892	CpG island
KRT17P1	CpG island
ENSG00000240505	chromatin interactions
ENSG00000229749	chromatin interactions
ENSG00000205312	chromatin interactions
ENSG00000179598	chromatin interactions

Extended variants
information (count: 5989 )
Associated
traits (count: 162 )

Variant overlapped rSNPs/rCNVs (count:5989 , 50 per page) page: 1 2 3 4 5 6 7 ... 120

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs567158807	chr17:16670807-16670808	Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs529917561	chr17:16670827-16670828	Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs549712383	chr17:16670836-16670837	Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs3907706	chr17:16670853-16670854	Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs568903118	chr17:16670882-16670883	Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs3907707	chr17:16670890-16670891	Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs538250040	chr17:16670912-16670913	Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs557921480	chr17:16670921-16670922	Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs7215888	chr17:16670957-16670958	Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs371701567	chr17:16670993-16670994	Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs3907708	chr17:16671017-16671018	Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs3907709	chr17:16671029-16671030	Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs549776752	chr17:16671041-16671042	Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs184700579	chr17:16671105-16671106	Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs189973770	chr17:16671142-16671143	Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs574309522	chr17:16671183-16671184	Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs543338951	chr17:16671219-16671220	Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs556935017	chr17:16671241-16671242	Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs374119492	chr17:16671288-16671289	Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs145246700	chr17:16671374-16671375	Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs564800936	chr17:16671388-16671389	Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs527364803	chr17:16671586-16671587	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs62075073	chr17:16671587-16671588	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs113103159	chr17:16671589-16671590	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs180774081	chr17:16671617-16671618	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs148291654	chr17:16671631-16671632	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs200955928	chr17:16671681-16671682	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs563242939	chr17:16671715-16671716	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs531577202	chr17:16671803-16671804	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs551764612	chr17:16672022-16672023	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs571589618	chr17:16672026-16672027	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs77640137	chr17:16672087-16672088	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs183673130	chr17:16672101-16672102	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs547960103	chr17:16672114-16672115	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs567851846	chr17:16672123-16672124	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs3101947	chr17:16672125-16672126	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs536847973	chr17:16672161-16672162	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs369945923	chr17:16672212-16672213	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs372894705	chr17:16672225-16672226	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs3114287	chr17:16672331-16672332	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs150755336	chr17:16672360-16672361	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs139096448	chr17:16672389-16672390	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs113939896	chr17:16672407-16672408	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs538998173	chr17:16672465-16672466	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs201292043	chr17:16672469-16672470	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs558503153	chr17:16672516-16672517	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs571993181	chr17:16672544-16672545	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs541110935	chr17:16672551-16672552	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs144554386	chr17:16672612-16672613	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs147844859	chr17:16672625-16672626	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:162)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Burkitt''s lymphoma	19759907	CNVD
Wilms tumour	21544195	CNVD
Esophageal adenocarcinoma	18519675	CNVD
lymphocytic leukemia	21291569	CNVD
Acute lymphoblastic leukemia	21390130	CNVD
Melanoma	18172304	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	16608533	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Chordoma	21602918	CNVD
Miller-Dieker syndrome	22283845	CNVD
Non-syndromic sensorineural hearing loss	17457615	CNVD
Cancer	22429812	CNVD
Chronic lymphocytic leukemia	21795749	CNVD
Ewing''s sarcoma	21437220	CNVD
Follicular lymphoma	19010834	CNVD
Colorectal cancer	20709793	CNVD
Acute myeloid leukemia	16864856	CNVD
Endometrial cancer	22040021	CNVD
Paraganglioma	21461997	CNVD
Pheochromocytoma	21461997	CNVD
Breast cancer	22028636	CNVD
Breast cancer	20837533	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Hepatocellular carcinoma	22174799	CNVD
Medulloblastoma	21292688	CNVD
colon cancer	17210682	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Basal cell lymphoma	17053054	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Cancer	16751803	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Colorectal cancer	19359472	CNVD
Embryonal rhabdomyosarcoma	16790082	CNVD
Chronic lymphocytic leukemia	17971485	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16461572	CNVD
Colorectal cancer	16272173	CNVD
Follicular lymphoma	17170743	CNVD
Human rectal carcinomas	16397240	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Breast cancer	17133270	CNVD
Chronic lymphocytic leukemia	18922857	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Ovarian cancer	22174824	CNVD
Moyamoya disease	22323933	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute promyelocytic leukemia	19109227	CNVD
Urothelial carcinoma	21177765	CNVD
Acute myeloid leukemia	21251322	CNVD
Myelodysplastic syndrome	21251322	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Acute myeloid leukemia	20724749	CNVD
Non-syndromic sensorineural hearing loss	21030649	CNVD
Acute myeloid leukemia	17237825	CNVD
Colorectal cancer	21645411	CNVD
HIV/AIDS	22844521	CNVD
Psoriasis	22844521	CNVD
Rheumatoid arthritis	22844521	CNVD
Sclerosis systemic	22844521	CNVD
Systemic lupus erythematosus	22844521	CNVD
HIV/AIDS	17953491	CNVD
HIV/AIDS	20877625	CNVD
Immune disease	21076436	CNVD
Rheumatoid arthritis	17953491	CNVD
Type 1 diabetes	17953491	CNVD
HIV/AIDS	15637236	CNVD
Prostate cancer	18632612	CNVD
Lung cancer	18438408	CNVD
Ovarian cancer	21781307	CNVD
Autism	22495311	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Neurofibromatosis	18196300	CNVD
Adenoid cystic carcinoma	18332873	CNVD
Colorectal cancer	16774939	CNVD
Pancreatic cancer	21811587	CNVD
Breast cancer	17001317	CNVD
Rhabdomyosarcoma	16790082	CNVD
Charcot-marie-tooth disease	16463004	CNVD
Osteosarcoma	22292074	CNVD
Breast cancer	17603634	CNVD
Charcot	16760730	CNVD
Mental retardation	17901693	CNVD
Malignant fibrous histiocytomas	21085701	CNVD
ovarian endometriomas	16273235	CNVD
Ovarian cancer	21720365	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Gastric cancer	18160780	CNVD
Smith-Magenis syndrome	18923513	CNVD
Invasive pancreatic ductal carcinoma	16982739	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16272173	CNVD
Austim spectrum disorder	21302340	CNVD
Autism	22492990	CNVD
Congenital abnormalities	21549014	CNVD
Developmental delay	18414209	CNVD
Developmental delay	21549014	CNVD
Epilepsy	20970697	CNVD
Mental retardation	18414209	CNVD
Mental retardation	21549014	CNVD
Smith-Magenis syndrome	21981782	CNVD
Smith-Magenis syndrome	20188345	CNVD
Smith-Magenis syndrome	16775514	CNVD
Smith-Magenis syndrome	22585170	CNVD
Smith-Magenis syndrome	22241247	CNVD
Autism	20970697	CNVD
Mental retardation	19951919	CNVD
Potocki-Lupski syndrome	21271655	CNVD
Potocki-lupski syndrome	17357070	CNVD
Potocki-lupski syndrome	20110824	CNVD
Potocki-lupski syndrome	18923514	CNVD
Potocki-lupski syndrome	22241247	CNVD
Potocki-lupski syndrome	20188345	CNVD
Schizophrenia	21399695	CNVD
Mental retardation	16773131	CNVD
Adenocarcinoma	19607727	CNVD
Squamous cell cancer	19607727	CNVD
Non-small cell lung cancer	21829676	CNVD
Glioblastoma multiforme	17002787	CNVD
Charcot-marie-tooth disease	22470819	CNVD
Neurofibromatosis	22470819	CNVD
Neuropathy	22470819	CNVD
Smith-Magenis syndrome	18301319	CNVD
Smith-Magenis syndrome	17357070	CNVD
Smith-Magenis syndrome	18469339	CNVD
Smith-Magenis syndrome	22241097	CNVD
Smith-Magenis syndrome	22470819	CNVD
Tourette syndrome	18923514	CNVD
Type 1 diabetes	22470819	CNVD
Potocki-lupski syndrome	18469339	CNVD
Follicular lymphoma	20505157	CNVD
T-cell lymphomas	19863542	CNVD
Neuropathy	17597781	CNVD
Hepatocellular carcinoma	16750200	CNVD
Neurodevelopmental disorder	17015230	CNVD
Smith-Magenis syndrome	17597781	CNVD
Potocki-lupski syndrome	18059269	CNVD
Potocki-lupski syndrome	17597781	CNVD
Mental retardation	17847001	CNVD
Multiple myeloma	16616336	CNVD
Breast cancer	20409316	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
Breast cancer	21509527	CNVD
Ductal carcinoma	22052326	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Multiple myeloma	17550852	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:812 , 50 per page) page: 1 2 3 4 5 6 7 ... 17

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr17:16670800-16671400	Enhancers	Duodenum Mucosa	Duodenum
2	chr17:16671200-16671400	Enhancers	Primary monocytes fromperipheralblood	blood
3	chr17:16671200-16672000	Enhancers	Colon Smooth Muscle	Colon
4	chr17:16671400-16672400	Weak transcription	Duodenum Mucosa	Duodenum
5	chr17:16671400-16678600	Weak transcription	Primary monocytes fromperipheralblood	blood
6	chr17:16672400-16672600	Enhancers	Duodenum Mucosa	Duodenum
7	chr17:16676000-16676800	Enhancers	HMEC	breast
8	chr17:16685200-16695400	Weak transcription	Rectal Mucosa Donor 29	rectum
9	chr17:16689000-16697600	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
10	chr17:16689600-16711600	Weak transcription	Skeletal Muscle Male	skeletal muscle
11	chr17:16690000-16706000	Weak transcription	Primary T cells fromperipheralblood	blood
12	chr17:16690400-16696000	Weak transcription	Brain Anterior Caudate	brain
13	chr17:16691200-16691600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
14	chr17:16692800-16693000	Enhancers	Duodenum Mucosa	Duodenum
15	chr17:16693000-16697600	Weak transcription	Duodenum Mucosa	Duodenum
16	chr17:16695400-16695600	Enhancers	Rectal Mucosa Donor 29	rectum
17	chr17:16697600-16698000	Enhancers	Primary monocytes fromperipheralblood	blood
18	chr17:16697600-16698000	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
19	chr17:16697600-16698000	Enhancers	Duodenum Mucosa	Duodenum
20	chr17:16697600-16698000	Enhancers	A549	lung
21	chr17:16697600-16698000	Enhancers	K562	blood
22	chr17:16697800-16698000	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
23	chr17:16698000-16704200	Weak transcription	Primary hematopoietic stem cells G-CSF-mobilized Male	--
24	chr17:16698000-16710800	Weak transcription	Primary monocytes fromperipheralblood	blood
25	chr17:16698000-16711800	Weak transcription	Primary mononuclear cells fromperipheralblood	Blood
26	chr17:16698800-16705200	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
27	chr17:16700000-16700200	Enhancers	ES-I3 Cell Line	embryonic stem cell
28	chr17:16700200-16708200	Weak transcription	ES-I3 Cell Line	embryonic stem cell
29	chr17:16708200-16708600	Enhancers	ES-I3 Cell Line	embryonic stem cell
30	chr17:16708200-16708600	Enhancers	H1 BMP4 Derived Trophoblast Cultured Cells	ES cell derived
31	chr17:16708200-16708600	Enhancers	HUES6 Cell Line	embryonic stem cell
32	chr17:16711600-16711800	Enhancers	Skeletal Muscle Male	skeletal muscle
33	chr17:16716600-16723200	Weak transcription	Right Atrium	heart
34	chr17:16717200-16720000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
35	chr17:16717400-16717600	Enhancers	Skeletal Muscle Male	skeletal muscle
36	chr17:16717400-16717800	Weak transcription	iPS DF 19.11 Cell Line	embryonic stem cell
37	chr17:16717600-16717800	Bivalent Enhancer	Foreskin Melanocyte Primary Cells skin01	Skin
38	chr17:16717600-16718000	Flanking Active TSS	Skeletal Muscle Male	skeletal muscle
39	chr17:16717600-16718200	Bivalent Enhancer	Fetal Muscle Leg	muscle
40	chr17:16717600-16718200	Enhancers	Right Ventricle	heart
41	chr17:16717600-16718200	Enhancers	Skeletal Muscle Female	skeletal muscle
42	chr17:16717800-16719000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
43	chr17:16718000-16719000	Bivalent Enhancer	Skeletal Muscle Male	skeletal muscle
44	chr17:16718000-16719000	ZNF genes & repeats	Spleen	Spleen
45	chr17:16718600-16719200	Enhancers	A549	lung
46	chr17:16718600-16720600	Weak transcription	Placenta Amnion	Placenta Amnion
47	chr17:16719000-16719200	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
48	chr17:16719000-16719200	Enhancers	NHEK	skin
49	chr17:16719000-16719400	Enhancers	Foreskin Keratinocyte Primary Cells skin03	Skin
50	chr17:16719000-16723200	Weak transcription	Spleen	Spleen

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links